Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis-Reference-Cited by-同舟云学术

Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis

Published:2021-06-28 Issue:2 Volume:88 Page:441-451
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Pastori Daniele¹^ORCID,Pani Arianna²,Di Rocco Arianna³,Menichelli Danilo¹,Gazzaniga Gianluca²,Farcomeni Alessio⁴,D'Erasmo Laura⁵,Angelico Francesco³,Del Ben Maria¹,Baratta Francesco¹

Affiliation:

1. Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences Sapienza University of Rome Italy

2. Clinical Pharmacology Unit ASST Grande Ospedale Metropolitano Niguarda Milan Italy

3. Department of Public Health and Infectious Diseases Sapienza University of Rome Rome Italy

4. Department of Economics and Finance University of Rome Tor Vergata Rome Italy

5. Department of Translational and Precision Medicine Sapienza University of Rome Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14943

Reference57 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

3. Non-alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases

4. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes

5. Nonalcoholic Fatty Liver Disease and the Heart

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The biological characteristics of DAstV molecular epidemiology and pathogenicity of duck astrovirus causing hepatitis in ducks and chickens in Southeast China;Poultry Science;2024-10

2. News in gastroenterology, hepatology and digestive endoscopy;Vnitřní lékařství;2024-09-04

3. Current strategies for nonalcoholic fatty liver disease treatment (Review);International Journal of Molecular Medicine;2024-08-08

4. A promising therapy for fatty liver disease: PCSK9 inhibitors;Phytomedicine;2024-06

5. Association between serum alanine transaminase/aspartate aminotransferase (ALT/AST) ratio and cognitive impairment in US older adults;2024-05-06